Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Share-based Compensation (2016 - 2024)

Avricore Health has reported Share-based Compensation over the past 11 years, most recently at $124567.1 for Q4 2024.

  • Quarterly Share-based Compensation rose 18.79% to $124567.1 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $393954.1 through Dec 2024, down 24.59% year-over-year, with the annual reading at $395265.9 for FY2024, 24.21% down from the prior year.
  • Share-based Compensation was $124567.1 for Q4 2024 at Avricore Health, down from $247837.3 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $305717.0 in Q1 2021 and troughed at $1168.4 in Q2 2024.
  • The 5-year median for Share-based Compensation is $65094.0 (2023), against an average of $96985.9.
  • Year-over-year, Share-based Compensation skyrocketed 2361.04% in 2022 and then tumbled 99.07% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $92193.1 in 2020, then plummeted by 92.11% to $7274.1 in 2021, then skyrocketed by 2361.04% to $179018.8 in 2022, then crashed by 41.42% to $104866.0 in 2023, then rose by 18.79% to $124567.1 in 2024.
  • Per Business Quant, the three most recent readings for AVCRF's Share-based Compensation are $124567.1 (Q4 2024), $247837.3 (Q3 2024), and $1168.4 (Q2 2024).